A report on testing for severe combined immune deficiency (SCID) in New Zealand as part of the Newborn Metabolic Screening Programme. It was prepared for the National Screening Unit by Health Partners Consulting Group Ltd.
Background and external link to the New Zealand Medical Journal article "Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage" by Dr Hazel Lewis.
This literature review was intended to inform an economic analysis of the cost-effectiveness of including testing for Severe Combined Immune Deficiency (SCID) in the Newborn Metabolic Screening Programme. It was prepared for the National Screening Unit by Health Partners Consulting Group Ltd.
The purpose of this report is to present information on 2 year interval breast cancers from the BreastScreen Aotearoa (BSA) mammographic screening programme and to compare this with published results from other services.